Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





Income Statement
Balance Sheet
Cash Flow Statement

Common Size IS
Op Efficiency
Credit Analysis

Vitae Pharmaceuticals, Inc (VTAE)

Income Statement

Standardized | As Reported Annual | Quarterly | TTM
  Older >>
In millions, except per share itemsJun-30-16Mar-31-16Dec-31-15Sep-30-15Jun-30-15Mar-31-15Dec-31-14Sep-30-14
   10-Q10-Q10-K10-Q10-Q10-Q10-K10-Q
Revenues  0.30.50.60.66.77.68.7-11,088.5
            Revenue growth  -95.2%-93.7%-93.3%-100.0%-100.1%   
Cost of goods sold  33.433.433.421.121.121.121.1-3,777.4
Gross profit  -33.0-32.9-32.8-20.4-14.4-13.4-12.4-7,311.1
            Gross margin  -10243.3%-6837.4%-5654.0%-3148.0%-217.0%-175.8%-143.3%65.9%
Selling, general and administrative   [+]10.19.79.39.29.78.87.93,996.8
Research and development  35.835.735.631.025.222.319.314.2
Other operating expenses    -33.4   -21.1 
EBITDA   [+]-45.3-44.7-44.1-39.4-27.9-23.2-18.37,626.7
            EBITDA margin  -14061.4%-9292.8%-7602.6%-6066.7%-420.2%-303.1%-211.5%-68.8%
Depreciation and amortization  0.20.20.20.20.20.20.2-158.3
EBIT   [+]-45.6-44.9-44.3-39.6-28.2-23.4-18.57,784.9
            EBIT margin  -14131.5%-9340.0%-7640.5%-6100.3%-423.4%-305.8%-214.0%-70.2%
Interest expense, net   [+]-0.4-0.4-0.30.00.30.70.91,052.9
Other income (expense), net   [+]  0.1 -0.10.1 1,801.1
Pre-tax income  -44.9-44.3-44.0-39.8-28.6-23.9-19.18,533.2
Income taxes  0.00.00.00.00.00.00.00.0
            Tax rate  0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%
Net income  -44.9-44.3-44.0-39.8-28.6-23.9-19.18,533.2
            Net margin  -13933.5%-9210.6%-7587.5%-6131.5%-429.3%-312.9%-220.4%-77.0%
   
Basic EPS   [+]($1.89)($2.01)($2.03)($1.93)($1.83)($2.32)($3.63)$60.30
Diluted EPS   [+]($1.89)($2.02)($2.04)($2.28)($2.30)($3.37)($9.32)$60.30
   
Shares outstanding (basic)   [+]23.822.021.620.715.610.35.3141.5
Shares outstanding (diluted)   [+]23.722.021.517.512.47.12.0141.5
   
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.  

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy